Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P080025/S353

InterStim Therapy System, Verify Evaluation System

Medtronic Neuromodulation · Decision date Oct 9, 2026

MEDTECHLEDGER EXPLANATIONP080025/S353

What did the FDA decide?

The FDA record for P080025/S353 describes a 30-day notice submitted by Medtronic Neuromodulation covering a process change attributed to a manufacturer, sterilizer, packager or supplier. The stated purpose is approval for the introduction of a second Medium Rate (MR) Header's manufacturing line, designated MR Line 2, and to make inspection updates to the MR Headers Line currently in production at Medtronic Energy and Components Center (MECC), Brooklyn Center, MN.

The product code QON places this under an implanted electrical device intended for treatment of fecal incontinence, with specialties listed as gastroenterology and urology. The supplement number establishes a relationship to the original PMA P080025, but this notice is a manufacturing change, not a new approval of the entire InterStim Therapy System or Verify Evaluation System. The record does not report clinical data, safety or effectiveness findings, or line-level technical specifications, so those details are absent rather than established by this entry.

FDA approval order statement

approval for the introduction of a second Medium Rate (MR) Headers manufacturing line (MR Line 2) and to make inspection updates to the MR Headers Line that is currently in production at Medtronic Energy and Components Center (MECC), Brooklyn Center, MN.
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Gastroenterology, Urology
Decision date
Oct 9, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P080025/S353
Regulatory pathway
PMA supplement
Product code
QON
Decision code
OK30
Decision date
Oct 9, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implanted electrical device intended for treatment of fecal incontinence.

Product code
QON
FDA device class
3

For the original device and its historical approval scope, see PMA P080025. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P080025 · Original PMA

    MEDTRONIC INTERSTIM SACRAL NERVE STIMULATION THERAPY SYSTEM

  2. P080025/S353 received

    Application receipt date recorded by FDA.

  3. P080025/S352 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  4. P080025/S351 · Related supplement

    lnterStim Therapy System, Verify Evaluation System

  5. P080025/S353 · FDA decision

    30-Day Notice

  6. P080025/S354 · Related supplement

    InterStim Therapy System, Verify Evaluation System (SNS Bowel Neurostimulator 97800), (SNS Bowel Neurostimulators Impl

Timeline entries are records held by MedtechLedger for P080025. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P080025

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Neuromodulation

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
7000 Central Ave., NE, Ms Rcw225, Minneapolis, MN, 55432

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records